Peterson Kristine
Insider CIK 1508596 · ENTA Director · PRTK Director · PSDV Director · IMCR Director · AVBP Director · MLYS Director · IMGN Director · AMRN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MLYS Mineralys Therapeutics, In | A Award deriv | 2026-10-19 | 2026-10-20 | 16,600 | — | $0 | 16,600 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2026-10-19 | 2026-10-20 | 12,400 | — | $0 | 12,400 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | A Award deriv | 2026-06-18 | 2026-06-22 | 13,562 | — | $0 | 13,562 | SEC↗ |
| IMCR Immunocore Holdings plc | A Award deriv | 2026-05-27 | 2026-05-28 | 27,492 | — | $0 | 27,492 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2026-03-11 | 2026-03-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 15,502 | — | $0 | 15,502 | SEC↗ |
| IMCR Immunocore Holdings plc | A Award deriv | 2025-05-15 | 2025-05-19 | 26,198 | — | $0 | 26,198 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2025-03-13 | 2025-03-14 | 15,700 | — | $0 | 15,700 | SEC↗ |
| IMCR Immunocore Holdings plc | A Award deriv | 2024-05-23 | 2024-05-28 | 14,534 | — | $0 | 14,534 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | A Award deriv | 2024-04-22 | 2024-04-23 | 28,587 | — | $0 | 28,587 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2024-03-06 | 2024-03-08 | 15,700 | — | $0 | 15,700 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 50,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 13,090 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,597 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 74,954 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 5,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise deriv | 2023-11-30 | 2023-12-05 | 10,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise deriv | 2023-11-30 | 2023-12-05 | 10,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2023-11-30 | 2023-12-05 | 10,000 | $10.10 | $101.0K | 10,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | S Sale | 2023-11-30 | 2023-12-05 | 20,000 | $28.90 | $578.0K | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2023-11-30 | 2023-12-05 | 10,000 | $13.07 | $130.7K | 20,000 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | D To issuer deriv | 2023-09-21 | 2023-09-21 | 20,000 | — | $0 | 0 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | D To issuer deriv | 2023-09-21 | 2023-09-21 | 7,000 | — | $0 | 0 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | D To issuer deriv | 2023-09-21 | 2023-09-21 | 6,000 | — | $0 | 0 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | D To issuer deriv | 2023-09-21 | 2023-09-21 | 5,000 | — | $0 | 0 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | D To issuer deriv | 2023-09-21 | 2023-09-21 | 5,000 | — | $0 | 0 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | D To issuer deriv | 2023-09-21 | 2023-09-21 | 7,000 | — | $0 | 0 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | D To issuer | 2023-09-21 | 2023-09-21 | 59,000 | — | $0 | 20,000 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | D To issuer | 2023-09-21 | 2023-09-21 | 20,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise deriv | 2023-09-13 | 2023-09-14 | 10,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2023-09-13 | 2023-09-14 | 10,000 | $14.70 | $147.0K | 10,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2023-09-13 | 2023-09-14 | 10,000 | $16.08 | $160.8K | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 19,597 | — | $0 | 19,597 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 13,090 | — | $0 | 13,090 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2023-03-02 | 2023-03-06 | 10,800 | — | $0 | 10,800 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | A Award | 2023-02-08 | 2023-02-09 | 20,000 | — | $0 | 79,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2022-06-27 | 2022-06-29 | 115,919 | — | $0 | 115,919 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2022-06-27 | 2022-06-29 | 93,750 | — | $0 | 93,750 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 44,000 | $3.37 | $148.3K | 44,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 15,000 | — | $0 | 74,954 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2022-03-03 | 2022-03-07 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | A Award | 2022-02-16 | 2022-02-18 | 20,000 | — | $0 | 59,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 15,000 | — | $0 | 59,954 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 44,000 | $6.77 | $297.9K | 44,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2021-06-14 | 2021-06-16 | 45,953 | — | $0 | 45,953 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2021-06-14 | 2021-06-16 | 36,000 | — | $0 | 36,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2021-03-02 | 2021-03-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | A Award deriv | 2021-02-18 | 2021-02-22 | 7,000 | — | $0 | 7,000 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | A Award | 2021-02-18 | 2021-02-22 | 9,000 | — | $0 | 39,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2020-07-13 | 2020-07-15 | 34,805 | — | $0 | 34,805 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2020-07-13 | 2020-07-15 | 27,191 | — | $0 | 27,191 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2020-06-17 | 2020-06-18 | 17,000 | — | $0 | 44,954 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2020-06-17 | 2020-06-18 | 50,000 | $4.56 | $228.0K | 50,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2020-02-28 | 2020-03-03 | 19,000 | — | $0 | 19,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2020-02-28 | 2020-03-03 | 33,500 | — | $0 | 33,500 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2020-02-26 | 2020-02-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | A Award deriv | 2020-02-19 | 2020-02-21 | 7,000 | — | $0 | 7,000 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | A Award | 2020-02-19 | 2020-02-21 | 9,000 | — | $0 | 30,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2019-06-25 | 2019-06-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2019-06-21 | 2019-06-24 | 6,667 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2019-06-21 | 2019-06-24 | 6,667 | — | $0 | 6,667 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2019-06-20 | 2019-06-24 | 18,000 | $2.10 | $37.8K | 18,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2019-06-20 | 2019-06-24 | 4,000 | — | $0 | 27,954 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2019-05-20 | 2019-05-21 | 7,428 | — | $0 | 7,428 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2019-05-20 | 2019-05-21 | 9,658 | — | $0 | 9,658 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2019-02-28 | 2019-03-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | A Award deriv | 2019-02-26 | 2019-02-28 | 5,000 | — | $0 | 5,000 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | A Award | 2019-02-26 | 2019-02-28 | 7,500 | — | $0 | 21,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-02-22 | 2019-02-22 | 30,000 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-02-22 | 2019-02-22 | 13,500 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-02-22 | 2019-02-22 | 120,000 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-02-22 | 2019-02-22 | 30,000 | $14.40 | $432.0K | 150,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-02-22 | 2019-02-22 | 120,000 | $3.67 | $440.4K | 120,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-02-22 | 2019-02-22 | 13,500 | $5.58 | $75.3K | 163,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-02-22 | 2019-02-22 | 163,500 | $20.02 | $3.27M | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2018-06-21 | 2018-06-26 | 26,667 | — | $0 | 26,667 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2018-06-21 | 2018-06-26 | 6,667 | — | $0 | 6,667 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2018-06-21 | 2018-06-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2018-06-20 | 2018-06-22 | 18,000 | $11.21 | $201.8K | 18,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2018-06-20 | 2018-06-22 | 4,000 | — | $0 | 23,954 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2018-05-14 | 2018-10-02 | 46,973 | — | $0 | 46,973 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2018-05-14 | 2018-10-02 | 31,153 | — | $0 | 31,153 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2018-02-28 | 2018-03-05 | 3,750 | — | $0 | 3,750 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | A Award deriv | 2018-02-14 | 2018-02-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | A Award | 2018-02-14 | 2018-02-16 | 7,500 | — | $0 | 13,500 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2017-12-15 | 2017-12-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2017-09-11 | 2017-09-13 | 12,500 | — | $0 | 12,500 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2017-06-13 | 2017-06-15 | 3,000 | — | $0 | 19,954 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2017-06-13 | 2017-06-15 | 10,000 | $4.64 | $46.4K | 10,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2017-05-15 | 2017-05-17 | 14,706 | — | $0 | 14,706 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2017-05-15 | 2017-05-17 | 21,146 | — | $0 | 21,146 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | A Award deriv | 2017-02-02 | 2017-02-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | A Award | 2017-02-02 | 2017-02-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2016-12-09 | 2016-12-13 | 5,000 | $1.84 | $9.2K | 5,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2016-12-09 | 2016-12-13 | 1,500 | — | $0 | 16,954 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2016-07-11 | 2016-07-13 | 20,548 | — | $0 | 20,548 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2016-07-11 | 2016-07-13 | 28,847 | — | $0 | 28,847 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | A Award deriv | 2016-03-31 | 2016-03-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2015-11-10 | 2015-11-12 | 3,000 | — | $0 | 15,454 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2015-11-10 | 2015-11-12 | 10,000 | $13.07 | $130.7K | 10,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 17,358 | — | $0 | 17,358 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 23,144 | — | $0 | 23,144 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 40,500 | — | $0 | 40,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 18,000 | — | $0 | 18,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2014-11-11 | 2014-11-12 | 10,000 | $10.10 | $101.0K | 10,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2014-11-11 | 2014-11-12 | 3,000 | — | $0 | 12,454 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2014-03-11 | 2014-03-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2014-03-11 | 2014-03-13 | 28,500 | — | $0 | 28,500 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2013-11-12 | 2013-11-13 | 10,000 | $14.70 | $147.0K | 10,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2013-11-12 | 2013-11-13 | 3,000 | — | $0 | 3,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2013-07-09 | 2013-07-11 | 13,500 | — | $0 | 13,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2013-07-09 | 2013-07-11 | 9,000 | — | $0 | 9,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2013-01-30 | 2013-01-31 | 1,768 | — | $0 | 1,768 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2012-11-13 | 2012-11-15 | 4,645 | $11.42 | $53.0K | 4,645 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2012-07-10 | 2012-07-12 | 30,000 | — | $0 | 30,000 | SEC↗ |